Marcia L. Stefanick, Ph.D.
Publication Details
-
Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer.
J Natl Cancer Inst. 2011; (6): 470-7
Triple-negative (ie, estrogen receptor [ER], progesterone receptor, and HER2 negative) breast cancer occurs disproportionately among African American women compared with white women and is associated with a worse prognosis than ER-positive (ER+) breast cancer. Hormonally mediated risk factors may be differentially related to risk of triple-negative and ER+ breast cancers.
Help
Trial Administration